ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

Abstract
Keywords
Introduction
Material and methods
Patients
Data collection design
Statistical analysis
Results
Distribution of chc patient’s clinical features and risk factors#
Prevalence trends of hcv genotypes and risk factors by region and date of birth
Association between hcv genotypes and selected demographic and clinical features
Correlation between selected significant risk factors
Predictors among cirrhotic patients
Discussion
Abbreviations
Funding
Acknowledgments
Bibliography

DOI: 10.1016/S1665-2681(19)30758-6

Open Access

Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Download PDF

Linda E. Muñoz-Espinosa*,♦, Maria E. Trujillo-Trujillo***, Roberto F. Martínez-Macías*, Arturo Panduro***,♦, Ana M. Rivas-Estilla**, Nora A. Fierro***,♦, Ana L. Silvera-Linares*,♦, Rafael Torres-Valadez***, Paula Cordero-Pérez*,♦, Karina González-Aldaco***, Carlos Y. Chen-López*, Alexis José-Abrego***, Jaime R. Zuñiga-Noriega*, Maria C. Gutiérrez-Ruiz****,♦, Sonia Roman***,♦,

Corresponding author

soniamariaroman@hotmail.com

Correspondence and reprint request:

* Liver Unit and Molecular Medicine, Dr. José E. González, University Hospital. Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

** Department of Biochemistry and Molecular Medicine, Dr. José E. González, University Hospital. Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

*** Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, Fray Antonio Alcalde and Health Sciences University Center, University of Guadalajara, Guadalajara, Jalisco, Mexico

**** Health Sciences Department, Biological and Health Sciences Division, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City, Mexico

♦ Members of the “Red Temática de Colaboración Académica en Fisiopatología de las Enfermedades Hepáticas, SEP-Promep, Mexico”

Article

This article is available in English

Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Linda E. Muñoz-Espinosa, Maria E. Trujillo-Trujillo, Roberto F. Martínez-Macías, Arturo Panduro, Ana M. Rivas-Estilla, Nora A. Fierro, Ana L. Silvera-Linares, Rafael Torres-Valadez, Paula Cordero-Pérez, Karina González-Aldaco, Carlos Y. Chen-López, Alexis José-Abrego, Jaime R. Zuñiga-Noriega, Maria C. Gutiérrez-Ruiz, Sonia Roman

10.1016/S1665-2681(19)30758-6

Ann Hepatol. 2015;14:642-51

Indexed in:

Follow us:

Article

Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico

Subscribe to our newsletter